Last Updated: August 15, 2026

CLINICAL TRIALS PROFILE FOR HEPZATO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for HEPZATO

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT07281924 ↗	Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis	NOT_YET_RECRUITING	Delcath Systems Inc.	PHASE1	2025-12-01	This study is being done to see if combining HEPZATO KIT with nivolumab and relatlimab (Opdualag) in the first line setting in patients with metastatic melanoma with liver metastasis is safe, tolerable, and will have a synergistic effect leading to improved clinical outcomes compared to the historic cohort of patients with liver metastasis treated with combination immune checkpoint inhibitor therapy.
NCT07281924 ↗	Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis	NOT_YET_RECRUITING	University of Wisconsin, Madison	PHASE1	2025-12-01	This study is being done to see if combining HEPZATO KIT with nivolumab and relatlimab (Opdualag) in the first line setting in patients with metastatic melanoma with liver metastasis is safe, tolerable, and will have a synergistic effect leading to improved clinical outcomes compared to the historic cohort of patients with liver metastasis treated with combination immune checkpoint inhibitor therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for HEPZATO

Condition Name

Chart
Table

Condition Name for HEPZATO
Intervention	Trials
Liver Metastases	1
Metastatic Melanoma	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for HEPZATO
Intervention	Trials
Melanoma	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for HEPZATO

Trials by Country

Map
Table

Trials by Country for HEPZATO
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for HEPZATO
Location	Trials
Wisconsin	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for HEPZATO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for HEPZATO
Clinical Trial Phase	Trials
PHASE1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for HEPZATO
Clinical Trial Phase	Trials
NOT_YET_RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for HEPZATO

Sponsor Name

Chart
Table

Sponsor Name for HEPZATO
Sponsor	Trials
Delcath Systems Inc.	1
University of Wisconsin, Madison	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for HEPZATO
Sponsor	Trials
INDUSTRY	1
OTHER	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.